187 related articles for article (PubMed ID: 10582766)
1. Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients.
Ito H; Miki C
Scand J Gastroenterol; 1999 Nov; 34(11):1139-43. PubMed ID: 10582766
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
[TBL] [Abstract][Full Text] [Related]
3. Nutritional status and postoperative cytokine response in colorectal cancer patients.
Hatada T; Miki C
Cytokine; 2000 Sep; 12(9):1331-6. PubMed ID: 10975992
[TBL] [Abstract][Full Text] [Related]
4. Intra-tumoral interleukin-6 down-regulation system and genetic mutations of tumor suppressor genes in colorectal carcinoma.
Miki C; Tonouchi H; Wakuda R; Hatada T; Inoue Y; Minato E; Kobayashi M; Kusunoki M
Cancer; 2002 Mar; 94(5):1584-92. PubMed ID: 11920517
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 receptor antagonists and other markers in colorectal cancer patients.
Iwagaki H; Hizuta A; Tanaka N
Scand J Gastroenterol; 1997 Jun; 32(6):577-81. PubMed ID: 9200291
[TBL] [Abstract][Full Text] [Related]
6. CRP, TNF-alpha, IL-1ra, IL-6, IL-8 and IL-10 in blood serum of colorectal cancer patients.
Kamińska J; Kowalska MM; Nowacki MP; Chwaliński MG; Rysińska A; Fuksiewicz M
Pathol Oncol Res; 2000; 6(1):38-41. PubMed ID: 10749586
[TBL] [Abstract][Full Text] [Related]
7. Serum soluble interleukin-2 receptor in colorectal cancer.
Murakami S; Satomi A; Ishida K; Murai H; Okamura Y
Acta Oncol; 1994; 33(1):19-21. PubMed ID: 8142118
[TBL] [Abstract][Full Text] [Related]
8. Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma.
Fukuura T; Miki C; Inoue T; Matsumoto K; Suzuki H
Br J Cancer; 1998 Aug; 78(4):454-9. PubMed ID: 9716026
[TBL] [Abstract][Full Text] [Related]
9. Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma.
Kinoshita T; Ito H; Miki C
Cancer; 1999 Jun; 85(12):2526-31. PubMed ID: 10375098
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 levels in colorectal cancer tissues.
Komoda H; Tanaka Y; Honda M; Matsuo Y; Hazama K; Takao T
World J Surg; 1998 Aug; 22(8):895-8. PubMed ID: 9673566
[TBL] [Abstract][Full Text] [Related]
11. Serum-soluble interleukin-2 receptor concentrations in patients with gastric cancer.
Murakami S; Satomi A; Ishida K; Murai H; Matsuki M; Hashimoto T
Cancer; 1994 Nov; 74(10):2745-8. PubMed ID: 7525035
[TBL] [Abstract][Full Text] [Related]
12. The relationship between circulating interleukin-6 and carcinoembryonic antigen in patients with colorectal cancer.
Nakagoe T; Tsuji T; Sawai T; Tanaka K; Hidaka S; Shibasaki S; Nanashima A; Yamaguchi H; Yasutake T; Sugawara K; Inokuchi N; Kamihira S
Anticancer Res; 2003; 23(4):3561-4. PubMed ID: 12926107
[TBL] [Abstract][Full Text] [Related]
13. Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury.
Mandrup-Poulsen T; Wogensen LD; Jensen M; Svensson P; Nilsson P; Emdal T; Mølvig J; Dinarello CA; Nerup J
Crit Care Med; 1995 Jan; 23(1):26-33. PubMed ID: 8001382
[TBL] [Abstract][Full Text] [Related]
14. Serum immunosuppressive acidic protein reflects systemic deterioration of colorectal cancer patient condition.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Koike Y; Watanabe H; Yokoe T; Hiro J; Ojima E; Tanaka K; Kusunoki M
J Surg Oncol; 2008 Apr; 97(5):404-8. PubMed ID: 18181167
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 receptor antagonist mRNA expression and the progression of gastric carcinoma.
Iizuka N; Hazama S; Hirose K; Abe T; Tokuda N; Fukumoto T; Tangoku A; Oka M
Cancer Lett; 1999 Aug; 142(2):179-84. PubMed ID: 10463774
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-10 and interleukin-1 receptor antagonists increase during cardiac surgery.
Kawamura T; Wakusawa R; Inada K
Can J Anaesth; 1997 Jan; 44(1):38-42. PubMed ID: 8988822
[TBL] [Abstract][Full Text] [Related]
17. Levels of serum-soluble receptor for interleukin-2 in patients with colorectal cancer.
Saito H; Tsujitani S; Katano K; Ikeguchi M; Maeta M; Kaibara N
Surg Today; 1998; 28(10):1115-7. PubMed ID: 9786595
[TBL] [Abstract][Full Text] [Related]
18. Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners.
Neidhart M; Müller-Ladner U; Frey W; Bosserhoff AK; Colombani PC; Frey-Rindova P; Hummel KM; Gay RE; Häuselmann H; Gay S
Osteoarthritis Cartilage; 2000 May; 8(3):222-9. PubMed ID: 10806050
[TBL] [Abstract][Full Text] [Related]
19. Decreased interleukin-1 receptor antagonist response following moderate exercise in patients with colorectal carcinoma after primary treatment.
Allgayer H; Nicolaus S; Schreiber S
Cancer Detect Prev; 2004; 28(3):208-13. PubMed ID: 15225901
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I--an independent prognostic factor.
Kaminska J; Nowacki MP; Kowalska M; Rysinska A; Chwalinski M; Fuksiewicz M; Michalski W; Chechlinska M
Tumour Biol; 2005; 26(4):186-94. PubMed ID: 16006772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
